Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Long-Term Deferred Tax data on record, last reported at $45.6 million in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 27.03% year-over-year to $45.6 million; the TTM value through Sep 2025 reached $45.6 million, up 27.03%, while the annual FY2024 figure was $39.5 million, 40.93% up from the prior year.
  • Long-Term Deferred Tax reached $45.6 million in Q3 2025 per ORGO's latest filing, up from $41.8 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $45.6 million in Q3 2025 and bottomed at $18000.0 in Q1 2021.
  • Average Long-Term Deferred Tax over 5 years is $28.5 million, with a median of $32.0 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 177644.44% in 2021, then fell 6.7% in 2023.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $32.0 million in 2021, then decreased by 6.19% to $30.0 million in 2022, then decreased by 6.7% to $28.0 million in 2023, then skyrocketed by 40.93% to $39.5 million in 2024, then increased by 15.53% to $45.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $45.6 million in Q3 2025, $41.8 million in Q2 2025, and $40.7 million in Q1 2025.